KU
KURE.LSE KraneShares MSCI All China Health Care Index UCITS ETF USD
- USD
No recent price
- Total assets
- 1.50M
- Expense ratio
- 0.63%
- Dividend yield
- -
- 1-year return
- -18.84%
- Holdings
- 59
- Since
- 2021
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does KURE.LSE invest in?
Tracks Morningstar Gbl Health NR USD- Mostly Non-US stocks (99.2%)
- Largest sector: Healthcare (101.5%)
- Largest region: Asia Emerging (88.8%)
- Top 3 holdings: 21.9% of the fund
Asset allocation
- Non-US stocks 99.2%
- US stocks 3.9%
- Cash 0.4%
Top holdings
- Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A 7.83%
- Jiangsu Hengrui Medicine Co Ltd 7.46%
- BeOne Medicines AG 6.65%
- CSPC Pharmaceutical Group Ltd 4.01%
- Innovent Biologics Inc 3.92%
KraneShares MSCI All China Health Care Index UCITS ETF USD performance
Sharpe ratio -1.15- This year
- -19.79%
- 1 year
- -18.84%
- 3 years
- -23.22%
- 5 years
- 0.00%
Volatility 25.4% over 1 year and 25.5% over 3 years. High: expect large swings.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
KURE.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
KraneShares MSCI All China Health Care Index UCITS ETF USD top holdings
45.1% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A 300760.SHE | Healthcare | China | 7.83% |
| Jiangsu Hengrui Medicine Co Ltd 600276.SHG | Healthcare | China | 7.46% |
| BeOne Medicines AG 6160.HK | Healthcare | Hong Kong | 6.65% |
| CSPC Pharmaceutical Group Ltd 1093.HK | Healthcare | Hong Kong | 4.01% |
| Innovent Biologics Inc 1801.HK | Healthcare | Hong Kong | 3.92% |
| WuXi Biologics 2269.HK | Healthcare | Hong Kong | 3.81% |
| Zhangzhou Pientzehuang Pharmaceutical Co Ltd 600436.SHG | Healthcare | China | 3.20% |
| WuXi AppTec Co Ltd 603259.SHG | Healthcare | China | 2.75% |
| Aier Eye Hospital Group 300015.SHE | Healthcare | China | 2.72% |
| Sino Biopharmaceutical Ltd 1177.HK | Healthcare | Hong Kong | 2.70% |
The 10 largest of 59 holdings.
KURE.LSE sector exposure
- Healthcare101.5%
- Consumer Defensive0.8%
- Basic Materials0.8%
Share of the stocks in the fund.
KURE.LSE regional exposure
- Asia Emerging88.8%
- North America4.1%
- Asia Developed2.8%
Share of the stocks in the fund.
Company size
Average market cap 9.56B- Mega cap15.0%
- Big cap70.7%
- Medium cap8.8%
- Small cap1.3%
KraneShares MSCI All China Health Care Index UCITS ETF USD fund profile
- Fund name
- KraneShares MSCI All China Health Care Index UCITS ETF USD
- Ticker
- KURE.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Jan 14, 2021
- Trading currency
- USD
- Expense ratio
- 0.63%